Educational Materials and Image Induction Increase Treatment Credibility

References

• Andresen, E. M., J. A. Malmgren, W. B. Carter, and D. L. Patrick. 1994. Screening for depression in well older adults: Evaluation of a short form of the CES-D. American Journal of Preventive Medicine 10 (2):77–84. doi:10.1016/s0749-3797(18)30622-6.
   PubMed Web of Science ®Google Scholar
• Barnett, B. S., W. O. Siu, and H. G. Pope. 2018. A survey of American psychiatrists’ attitudes toward classic hallucinogens. Journal of Nervous and Mental Disease 206 (6):476–80. doi:10.1097/NMD.0000000000000828.
   PubMed Web of Science ®Google Scholar
• Beshai, S., L. M. Watson, T. J. S. Meadows, and J. N. Soucy. 2019. Perceptions of cognitive-behavioral therapy and antidepressant medication for depression after brief psychoeducation: Examining shifts in attitudes. Behavior Therapy 50 (5):851–63. doi:10.1016/j.beth.2019.01.001.
   PubMed Web of Science ®Google Scholar
• Bolkan, S., and P. A. Andersen. 2009. Image induction and social influence: Explication and initial tests. Basic and Applied Social Psychology 31 (4):317–24. doi:10.1080/01973530903316898.
   Web of Science ®Google Scholar
• Carhart-Harris, R., M. Bolstridge, C. M. J. Day, J. Rucker, R. Watts, D. Erritzoe, M. Kaelen, B. Giribaldi, M. Bloomfield, S. Pilling, et al. 2018. Psilocybin with psychological support for treatment-resistant depression: Six-month follow-up. Psychopharmacology 235 (2):399–408. doi:10.1007/s00213-017-4771-x.
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R. L., M. Bolstridge, J. Rucker, C. M. J. Day, D. Erritzoe, M. Kaelen, M. Bloomfield, J. A. Rickard, B. Forbes, A. Feilding, et al. 2016. Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study. The Lancet Psychiatry 3 (7):619–27. doi:10.1016/S2215-0366(16)30065-7.
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R., B. Giribaldi, R. Watts, M. Baker-Jones, A. Murphy-Beiner, R. Murphy, J. Martell, A. Blemings, D. Erritzoe, and D. J. Nutt. 2021. Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine 384 (15):1402–11. doi:10.1056/nejmoa2032994.
   PubMed Web of Science ®Google Scholar
• Cialdini, R. 2016. Pre-Suasion: A revolutionary way to influence and persuade. New York, NY: Simon & Schuster.
   Google Scholar
• Cialdini, R. B., N. Eisenberg, B. L. Green, K. Rhoads, and R. Bator. 1998. Undermining the undermining effect of reward on sustained interest. Journal of Applied Social Psychology 28 (3):249–63. doi:10.1111/j.1559-1816.1998.tb01705.x.
   Web of Science ®Google Scholar
• Close, J. B., E. C. Hajien, R. Watts, L. Roseman, and R. L. Carhart-Harris. 2020. Psychedelics and psychological flexibility – Results of a prospective web-survey using the acceptance and action questionnaire II. Journal of Contextual Behavioral Science 16:37–44. doi:10.1016/j.jcbs.2020.01.005.
   Web of Science ®Google Scholar
• Constantino, M. J., A. E. Coyne, J. F. Boswell, B. R. Iles, and A. Visla. 2018. A meta-analysis of the association between patients. Early Perception of Treatment Credibility and Their Posttreatment Outcomes. Psychotherapy 55 (4):486–95. doi:10.1037/pst0000168.
   PubMed Web of Science ®Google Scholar
• Corrigan, K., M. Haran, C. McCandliss, R. McManus, S. Cleary, R. Trant, Y. Kelly, K. Ledden, G. Rush, V. O’Keane, et al. 2021. Psychedelic perceptions: Mental health service user attitudes to psilocybin therapy. Irish Journal of Medical Science 191 (3):1385–97. doi:10.1007/s11845-021-02668-2.
   PubMed Web of Science ®Google Scholar
• Cuijpers, P. 2017. Four decades of outcome research on psychotherapies for adult depression: An overview of a series of meta-analyses. Canadian Psychology 58 (1):7–19. doi:10.1037/cap0000096.
   Web of Science ®Google Scholar
• Cuijpers, P., M. Berking, G. Andersson, L. Quigley, A. Kleiboer, and K. S. Dobson. 2013. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Canadian Journal of Psychiatry 58 (7):376–85. http://search.proquest.com/docview/1426313762?accountid=136549.
   PubMed Web of Science ®Google Scholar
• Curley, S., M. F. Smout, and L. A. Denson. 2019. Does behavioural activation lack credibility among those who need it most? A comparison of responses to rationales for behavioural activation and schema therapy. Behavioural and Cognitive Psychotherapy 47 (4):493–98. doi:10.1017/S135246581800067X.
   PubMed Web of Science ®Google Scholar
• Davis, A. K., F. S. Barrett, D. G. May, M. P. Cosimano, N. D. Sepeda, M. W. Johnson, P. H. Finan, and R. R. Griffiths. 2021. Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial. JAMA Psychiatry 78 (5):481–89. doi:10.1001/jamapsychiatry.2020.3285.
   PubMed Web of Science ®Google Scholar
• Devilly, G. J., and T. D. Borkovec. 2000. Psychometric properties of the credibility/expectancy questionnaire. Journal of Behavior Therapy and Experimental Psychiatry 31 (2):73–86. doi:10.1016/S0005-7916(00)00012-4.
   PubMed Web of Science ®Google Scholar
• Dore, J., B. Turnipseed, S. Dwyer, A. Turnipseed, J. Andries, G. Ascani, C. Monnette, A. Huidekoper, N. Strauss, and P. Wolfson. 2019. Ketamine Assisted Psychotherapy (KAP): Patient demographics, clinical data and outcomes in three large practices administering ketamine with psychotherapy. Journal of Psychoactive Drugs 51 (2):189–98. doi:10.1080/02791072.2019.1587556.
   PubMed Web of Science ®Google Scholar
• Doss, M. K., F. S. Barrett, and P. R. Corlett. 2022. Skepticism about recent evidence that psilocybin “Liberates” depressed minds. ACS Chemical Neuroscience 13 (17):2540–43. doi:10.1021/acschemneuro.2c00461.
   PubMed Web of Science ®Google Scholar
• Downey, R. G., and C. V. King. 1998. Missing data in Likert ratings: A comparison of replacement methods. Journal of General Psychology 125 (2):175–91. doi:10.1080/00221309809595542.
   PubMed Web of Science ®Google Scholar
• Earleywine, M., and Z. M. Herrmann. 2022. Psychedelics for psychiatric disorders: Promise, not panacea. Psychiatric Annals 52 (9):354–58. doi:10.3928/00485713-20220810-01.
   Web of Science ®Google Scholar
• Farrell, N. R., A. A. Lee, and B. J. Deacon. 2015. Biological or psychological? Effects of eating disorder psychoeducation on self-blame and recovery expectations among symptomatic individuals. Behaviour Research and Therapy 74:32–37. doi:10.1016/j.brat.2015.08.011.
   PubMed Web of Science ®Google Scholar
• Festinger, L. 1957. A theory of cognitive dissonance. Redwood City, California.: Stanford University Press.
   Google Scholar
• Fjermestad, K. W., M. D. Lerner, B. D. McLeod, G. J. H. Wergeland, B. S. M. Haugland, O. E. Havik, L. G. Öst, and W. K. Silverman. 2018. Motivation and treatment credibility predict alliance in cognitive behavioral treatment for youth with anxiety disorders in community clinics. Journal of Clinical Psychology 74 (6):793–805. doi:10.1002/jclp.22551.
   PubMed Web of Science ®Google Scholar
• Gable, R. S. 2004. Comparison of acute lethal toxicity of commonly abused psychoactive substances. Addiction 99 (6):686–96. doi:10.1111/j.1360-0443.2004.00744.x.
   PubMed Web of Science ®Google Scholar
• Goldman, M., M. Seever, and M. Seever. 1982. Social labeling and the foot-in-the-door effect. Journal of Social Psychology 117 (1):19–23. doi:10.1080/00224545.1982.9713402.
   Web of Science ®Google Scholar
• Griffiths, R. R., M. W. Johnson, M. A. Carducci, A. Umbricht, W. A. Richards, B. D. Richards, M. P. Cosimano, and M. A. Klinedinst. 2016. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology 30 (12):1181–97. doi:10.1177/0269881116675513.
   PubMed Web of Science ®Google Scholar
• Gukasyan, N., A. K. Davis, F. S. Barrett, M. P. Cosimano, N. D. Sepeda, M. W. Johnson, and R. R. Griffiths. 2022. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. Journal of Psychopharmacology 36 (2):151–58. doi:10.1177/02698811211073759.
   PubMed Web of Science ®Google Scholar
• Hasin, D. S., A. L. Sarvet, J. L. Meyers, T. D. Saha, W. J. Ruan, M. Stohl, and B. F. Grant. 2018. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry 75 (4):336–46. doi:10.1001/jamapsychiatry.2017.4602.
   PubMed Web of Science ®Google Scholar
• Hornsey, M. J. 2008. Social identity theory and self-categorization theory: A historical review. Social and Personality Psychology Compass 2 (1):204–22. doi:10.1111/j.1751-9004.2007.00066.x.
   Google Scholar
• Johnson, M. W., A. Garcia-Romeu, M. P. Cosimano, and R. R. Griffiths. 2014. Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology 28 (11):9983–92. doi:10.1177/0269881114548296.
   Web of Science ®Google Scholar
• Jordan, J., V. V. W. McIntosh, F. A. Carter, P. R. Joyce, C. M. A. Frampton, S. E. Luty, J. M. McKenzie, J. D. Carter, and C. M. Bulik. 2017. Predictors of premature termination from psychotherapy for anorexia nervosa: Low treatment credibility, early therapy alliance, and self-transcendence. International Journal of Eating Disorders 50 (8):979–83. doi:10.1002/eat.22726.
   PubMed Web of Science ®Google Scholar
• Kemper, N. S., D. S. Campbell, M. Earleywine, and A. K. Newheiser. 2019. Likert, slider, or text? Reassurances about response format effects. Addiction Research and Theory 28 (5):406–14. doi:10.1080/16066359.2019.1676892.
   Web of Science ®Google Scholar
• Kraut, R. E. 1973. Effects of social labeling on giving to charity. Journal of Experimental Social Psychology 9 (6):551–62. doi:10.1016/0022-1031(73)90037-1.
   Google Scholar
• Krebs, T. S., and P. Ø. Johansen. 2013. Over 30 million psychedelic users in the United States. F1000Research 2:98. doi:10.12688/f1000research.2-98.v1.
   PubMedGoogle Scholar
• Lequin, S., G. Grolleau, and N. Mzoughi. 2019. Harnessing the power of identity to encourage farmers to protect the environment. Environmental Science and Policy 93 (April 2018):112–17. doi:10.1016/j.envsci.2018.12.022.
   Google Scholar
• Liu, Q., H. He, J. Yang, X. Feng, F. Zhao, and J. Lyu. 2020. Changes in the global burden of depression from 1990 to 2017: Findings from the Global Burden of Disease study. Journal of Psychiatric Research 126 (June 2019):134–40. doi:10.1016/j.jpsychires.2019.08.002.
   PubMedGoogle Scholar
• McCulloch, D. E., M. Z. Grzywacz, M. K. Madsen, P. S. Jensen, B. Ozenne, S. Armand, G. M. Knudsen, P. M. Fisher, and D. S. Stenbæk. 2022. Psilocybin-induced mystical-type experiences are related to persisting positive effects: A quantitative and qualitative report. Frontiers in Pharmacology 13:841648. doi:10.3389/fphar.2022.841648.
   PubMed Web of Science ®Google Scholar
• Meade, A. W., and S. B. Craig. 2012. Identifying careless responses in survey data. Psychological Methods 17 (3):437–55. doi:10.1037/a0028085.
   PubMed Web of Science ®Google Scholar
• Miller, R. L., P. Brickman, and D. Bolen. 1975. Attribution versus persuasion as a means for modifying behavior. Journal of Personality and Social Psychology 31 (3):430–41. doi:10.1037/h0076539.
   PubMed Web of Science ®Google Scholar
• Nagata, T., Y. Fujino, M. Ohtani, K. Fujimoto, M. Nagata, S. Kajiki, M. Okawara, and K. Mori. 2020. Work functioning impairment in the course of pharmacotherapy treatment for depression. Scientific Reports 10 (1):15712. doi:10.1038/s41598-020-72677-1.
   PubMed Web of Science ®Google Scholar
• Palhano-Fontes, F., D. Barreto, H. Onias, K. C. Andrade, M. M. Novaes, J. A. Pessoa, S. A. Mota-Rolim, F. L. Osório, R. Sanches, R. G. Dos Santos, et al. 2019. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: A randomized placebo-controlled trial. Psychological Medicine 49 (4):655–63. doi:10.1017/S0033291718001356.
   PubMed Web of Science ®Google Scholar
• Park, E.-H., and M. H. Jung. 2019. The impact of major depressive disorder on adaptive function; A retrospective observational study. Medicine 98 (52):e18515. doi:10.1097/md.0000000000018515.
   PubMed Web of Science ®Google Scholar
• Reiff, C. M., E. E. Richman, C. B. Nemeroff, L. L. Carpenter, A. S. Widge, C. I. Rodriguez, N. H. Kalin, and W. M. McDonald. 2020. Psychedelics and psychedelic-assisted psychotherapy. American Journal of Psychiatry 177 (5):391–410. doi:10.1176/appi.ajp.2019.19010035.
   PubMed Web of Science ®Google Scholar
• Roseman, L., E. Haijen, K. Idialu-Ikato, M. Kaelen, R. Watts, and R. Carhart-Harris. 2019. Emotional breakthrough and psychedelics: Validation of the emotional breakthrough inventory. Journal of Psychopharmacology 33 (9):1076–87. doi:10.1177/0269881119855974.
   PubMed Web of Science ®Google Scholar
• Roseman, L., D. J. Nutt, and R. L. Carhart-Harris. 2018. Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Frontiers in Pharmacology 8:974. doi:10.3389/fphar.2017.00974.
   PubMed Web of Science ®Google Scholar
• Ross, S., A. Bossis, J. Guss, G. Agin-Liebes, T. Malone, B. Cohen, S. E. Mennenga, A. Belser, K. Kalliontzi, J. Babb, et al. 2016. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. Journal of Psychopharmacology 30 (12):1165–80. doi:10.1177/0269881116675512.
   PubMed Web of Science ®Google Scholar
• Rucker, J. J. H., L. A. Jelen, S. Flynn, K. D. Frowde, and A. H. Young. 2016. Psychedelics in the treatment of unipolar mood disorders: A systematic review. Journal of Psychopharmacology 30 (12):1220–29. doi:10.1177/0269881116679368.
   PubMed Web of Science ®Google Scholar
• Saarni, S. I., J. Suvisaari, H. Sintonen, S. Pirkola, S. Koskinen, A. Aromaa, and J. Lönnqvist. 2007. Impact of psychiatric disorders on health-related quality of life: General population survey. British Journal of Psychiatry 190 (4):326–32. doi:10.1192/bjp.bp.106.025106.
   PubMedGoogle Scholar
• Schenberg, E. E. 2018. Psychedelic-assisted psychotherapy: A paradigm shift in psychiatric research and development. Frontiers in Pharmacology 9 (JUL):1–11. doi:10.3389/fphar.2018.00733.
   PubMedGoogle Scholar
• Smeets, R. J. E. M., S. Beelen, M. E. J. B. Goossens, E. G. W. Schouten, J. A. Knottnerus, and J. W. S. Vlaeyen. 2008. Treatment expectancy and credibility are associated with the outcome of both physical and cognitive-behavioral treatment in chronic low back pain. Clinical Journal of Pain 24 (4):305–15. doi:10.1097/AJP.0b013e318164aa75.
   PubMed Web of Science ®Google Scholar
• Söchting, I., M. Tsai, and J. S. Ogrodniczuk. 2016. Patients’ perceptions of treatment credibility and their relation to the outcome of group CBT for depression. Archives of Psychiatry and Psychotherapy 18 (4):7–15. doi:10.12740/APP/66485.
   Google Scholar
• Vermetten, E., and R. Yehuda. 2020. MDMA-assisted psychotherapy for posttraumatic stress disorder: A promising novel approach to treatment. Neuropsychopharmacology 45 (1):231–32. doi:10.1038/s41386-019-0482-9.
   PubMed Web of Science ®Google Scholar
• Vittengl, J. R., L. A. Clark, T. W. Dunn, and R. B. Jarrett. 2007. Reducing relapse and recurrence in unipolar depression: A comparative meta-analysis of cognitive-behavioral therapy’s effects. Journal of Consulting and Clinical Psychology 75 (3):475–88. doi:10.1037/0022-006X.75.3.475.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2017. Depression and other common mental disorders: Global health estimates. World Health Organization. https://apps.who.int/iris/handle/10665/254610.
   Google Scholar